February 28, 2014 — Mercator MedSystems released pilot study data from a single-arm, open label study of 20 patients suffering with peripheral artery disease (PAD), which reveal sustained, positive clinical outcomes from baseline to 12 months and a one-year primary patency rate of 83 percent.
